Market Place
Sourcing Support
CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
08 Nov 2024 //
GLOBENEWSWIRE
CervoMed Announces Last Patient Visit In Phase 2b RewinD-LB Trial
15 Oct 2024 //
GLOBENEWSWIRE
CervoMed To Present Neflamapimod Biomarker Data In DLB At AAIC 2024
29 Jul 2024 //
GLOBENEWSWIRE
CervoMed To Host KOL Event On Neflamapimod For Lewy Body Dementia
11 Jul 2024 //
GLOBENEWSWIRE
CervoMed Completion Pha 2b RewinD-LB Clinical Trial of Neflamapimod
11 Jun 2024 //
GLOBENEWSWIRE
EIP Pharma Announces First Patient Dosed in Ph 2b Trial Evaluating Neflamapimod
14 Aug 2023 //
PR NEWSWIRE
EIP Pharma Publishes Data of Preclinical and Phase 2a Results for Neflamapimod
21 Sep 2022 //
BUSINESSWIRE
Lantern Pharma Announces Abstract on Effectiveness of LP-284 in ASH
04 Nov 2021 //
PRNEWSWIRE
EIP Pharma Announces Publication of Preclinical Results Demonstrating
16 Dec 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.